Merck And J&J Settle Remicade Dispute By Redrawing The Map
This article was originally published in The Pink Sheet Daily
Executive Summary
Rather than let an arbitration panel decide the fate of two anti-TNF drugs, Merck surrenders many territories but holds onto Europe.